Search research articles
Contact Us
Filters
Showing results (1-10 of 249) with videos related to
Page
of 25
Sort By:
Seminars in Nephrology
|
March 16, 2004
Angiotensin-converting enzyme inhibition and angiotensin II antagonism in nondiabetic chronic nephropathies
Piero Ruggenenti
Contributions to Nephrology
|
November 30, 2004
Chronic allograft nephropathy. A multiple approach to target nonimmunological factors
Piero Ruggenenti
Nephrologie & Therapeutique
|
June 5, 2017
Dual renin-angiotensin system blockade for nephroprotection
Piero Ruggenenti
Kidney International
|
August 8, 2002
Post-transplant hemolytic-uremic syndrome
Piero Ruggenenti
Nephron
|
February 2, 2023
The CARDINAL Trial of Bardoxolone Methyl in Alport Syndrome: When Marketing Interests Prevail over Patients Clinical Needs
Piero Ruggenenti
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia
|
December 14, 2016
Preventing nephropathy in type 2 diabetes
Piero Ruggenenti
The New England Journal of Medicine
|
July 4, 2019
A First Step toward a New Approach to Treating Membranous Nephropathy
Piero Ruggenenti, Giuseppe Remuzzi
Nature Reviews. Nephrology
|
July 30, 2009
Proteinuria: Is the ONTARGET renal substudy actually off target?
Piero Ruggenenti, Giuseppe Remuzzi
Nature Reviews. Nephrology
|
May 1, 2013
Renin-angiotensin system: Meta-analyses can misdirect decisions on treatment
Piero Ruggenenti, Giuseppe Remuzzi
American Journal of Nephrology
|
November 7, 2012
Dealing with renin-angiotensin inhibitors, don't mind serum creatinine
Piero Ruggenenti, Giuseppe Remuzzi
Page
of 25
Search research articles
Search
Showing results (1-10 of 249) with videos related to
Sort By:
Page
of 25
Seminars in Nephrology
|
March 16, 2004
Angiotensin-converting enzyme inhibition and angiotensin II antagonism in nondiabetic chronic nephropathies
Piero Ruggenenti
Contributions to Nephrology
|
November 30, 2004
Chronic allograft nephropathy. A multiple approach to target nonimmunological factors
Piero Ruggenenti
Nephrologie & Therapeutique
|
June 5, 2017
Dual renin-angiotensin system blockade for nephroprotection
Piero Ruggenenti
Kidney International
|
August 8, 2002
Post-transplant hemolytic-uremic syndrome
Piero Ruggenenti
Nephron
|
February 2, 2023
The CARDINAL Trial of Bardoxolone Methyl in Alport Syndrome: When Marketing Interests Prevail over Patients Clinical Needs
Piero Ruggenenti
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia
|
December 14, 2016
Preventing nephropathy in type 2 diabetes
Piero Ruggenenti
The New England Journal of Medicine
|
July 4, 2019
A First Step toward a New Approach to Treating Membranous Nephropathy
Piero Ruggenenti, Giuseppe Remuzzi
Nature Reviews. Nephrology
|
July 30, 2009
Proteinuria: Is the ONTARGET renal substudy actually off target?
Piero Ruggenenti, Giuseppe Remuzzi
Nature Reviews. Nephrology
|
May 1, 2013
Renin-angiotensin system: Meta-analyses can misdirect decisions on treatment
Piero Ruggenenti, Giuseppe Remuzzi
American Journal of Nephrology
|
November 7, 2012
Dealing with renin-angiotensin inhibitors, don't mind serum creatinine
Piero Ruggenenti, Giuseppe Remuzzi
Page
of 25